fdaoutsideweb

Mylan’s Ogivri becomes first and only FDA-approved Herceptin biosimilar

December 4, 2017
Sales and Marketing Biocon, Cancer, FDA, Herceptin, Mylan, Roche, biosimilar, pharma

The FDA has announced the approval of Mylan’s Ogivri (trastuzumab-dkst), the first biosimilar version of Roche’s Herceptin to be authorised …

J&J opts in on Idorsia’s candidate for $230m

December 4, 2017
Sales and Marketing Idorsia, Johnson & Johnson, biotech, drugs, pharma, pharmaceutical

As part of Johnson & Johnson’s acquisition of Actelion, it was able to secure a number of ties with the …

busch

Pharma carousel sees Bayer discovery chief head to Shire

December 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Shire, biotech, drugs, pharma, pharmaceutical

It’s no secret that when individuals leave companies within the pharma industry, they tend to pop up at a rival …

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

December 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

We’re officially into December and only one month away from the end of the year. Among our top news this …

fda_building_web

Gottlieb looking to approve cancer treatments on earlier evidence

December 1, 2017
Medical Communications FDA, Scott Gottlieb, biotech, drugs, pharma, pharmaceutical

Scott Gottlieb, FDA commissioner, was speaking in front of the House Committee on Energy and Commerce, regarding the 21st Century …

opioid_crisis

FDA approves first and only therapy of its kind for opioid addiction

December 1, 2017
Medical Communications, Sales and Marketing FDA, Invidior, Sublocade, US, opioid crisis, opioids, pharma

Image Credit:  Marco VerchAs the US languishes in the midst of an opioid crisis which President Trump declared national emergency …

diabetes-2424105_960_720

Type 1 diabetes misunderstood as “disease of childhood”

December 1, 2017
Medical Communications biotech, diabetes, drugs, pharma, pharmaceutical

New research published in The Lancet has revealed that type 1 diabetes cannot be understood as a “disease of the …

novartis_outside_1

Novartis reveals strong long-term data Cosentyx in psoriasis of the hands and feet

December 1, 2017
Medical Communications, Research and Development Cosentyx, Novartis, palmoplantar psoriasis, pharma, psoriasis

Novartis has released new data for Consentyx (secukinumab) which it claims make the IL-17A inhibitor “the first biologic to show …

online_v2

Vir Biotech appoint “renowned scientist” to CSO position

November 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vir Biotechnology, biotech, drugs, pharma, pharmaceutical

Vir Biotechnology, a developer of treatments that induce protective and therapeutics immune responses, has hired a CSO with a strong …

shutterstock_212432119

What’s driving change in drug discovery and development?

November 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Data, Lhasa limited, charity, drug discovery, pharma, pharmacovigilance

Dr Chris Barber, CEO of not-for-profit organisation and educational charity Lhasa Limited, discusses new innovations and ideas that are set …

kardia_band

ECG Kardia Band becomes first-ever FDA-approved medical device accessory for Apple Watch

November 30, 2017
Sales and Marketing Electrocardiogram, FDA, Kardia Band, apple watch, pharma

The FDA has announced its approval of AliveCor’s Kardia Band, an electrocardiogram for use with the Apple Watch, marking the …

mosquito-49141_960_720

Sanofi admits to dangers of its dengue vaccine

November 30, 2017
Sales and Marketing Sanofi, biotech, dengue, drugs, pharma, pharmaceutical

After analysing six years’ worth of data on its dengue vaccine, Dengvaxia, Sanofi contacted health authorities to tell them that …

headache

Novartis’ Phase 3 migraine data could revolutionise treatment

November 30, 2017
Research and Development CGRP, Novartis Amgen, biotech, drugs, migraine, pharma, pharmaceutical

Descriptions of treatments as ‘revolutionary’ or ‘ground-breaking’ are ten a penny in the pharmaceutical industry, very rarely do such treatments …

shutterstock_254160583

US federal government withdraws approval of major patient charity over donor misconduct

November 30, 2017
Medical Communications, Sales and Marketing Caring Voice Coalition, US, US government, patient charity, pharma

The Department of Health and Human Services’ Office of Inspector General (OIG) has rescinded authorisation for one of the US’ …

pixabay_puzzle-268905_640

European biotechs outperform US for investment return, report claims

November 29, 2017
Medical Communications, Sales and Marketing EU, Europe, US, investment, pharma

A new report from RSA Group has revealed that European biotech companies are “significantly outperforming” their US counterparts in terms …

heart-2372134_640

Human heart patch could repair dead tissue following heart attack

November 29, 2017
Research and Development Duke University, heart, heart patch, human heart, pharma

A team of researchers and biomedical engineers at Duke University in North Carolina, US, have revealed that they have developed …

Pfizer’s Viagra Connect becomes first erectile dysfunction drug available over-the-counter in UK

November 29, 2017
Research and Development, Sales and Marketing MHRA, Pfizer, Viagra Connect, erectile dysfunction, pharma, viagra

Pfizer has revealed that its erectile dysfunction treatment Viagra Connect (sildenafil) will now be available without a prescription through UK …

gilead-sciences

Gilead launches hep C drug Sovaldi in China at one-fifth of US price

November 29, 2017
Research and Development, Sales and Marketing China, Gilead, hepatitis C, pharma, sovaldi

Gilead has officially launched its hepatitis C drug Sovaldi (sofosbuvir) in the Chinese market, but with one major caveat: it …

scott_gottlieb

FDA unveils guidelines to help generic medical device versions reach the market

November 28, 2017
Research and Development, Sales and Marketing FDA, Mylan, Scott Gottlieb, auto injector, auto-injector, epipen, pharma

The scandal surrounding Mylan’s price-hiking of its flagship EpiPen epinephrine auto-injector was the news of last summer, continuing to grab …

mr058666-web

Merck KGaA and Pfizer’s Bavencio fails at Phase 3 in gastric cancer

November 28, 2017
Research and Development Bavencio, Cancer, Merck, Pfizer, pharma

Merck KGaA and Pfizer have been rocked by the news that their jointly-developed anti-PD-L1 antibody failed to meet its primary …

The Gateway to Local Adoption Series

Latest content